Solventum, World’s 14 th Largest Medical Device Company, moves to the cloud with SAP
Patient Centric & Future Focused
Published in 2024/25
Client Synopsis
What did they do?
Why did they do it?
• Solventum is a diversified Life Science company consisting of 4 divisions.
• The need to establish a standalone cloud-based enterprise application landscape by the end of a 24 month transition service agreement with 3M parent. • Minimize risk by leveraging proven and compliant Life Science best practice capabilities and a cloud operational model to minimize technical learning curve.
• 3M will spinout (1H 2024) their $8.6B
• Medical Solutions (54%) specializing in advanced wound care.
global Healthcare business as new public company called Solventum. The SpinCo has adopted a cloud-only enterprise application landscape leveraging greenfield approach and clean core principles. Their focus will be business agility, compliance and a lean operational model.
• Oral Care (15%) specializing in dental and orthodontic supplies. • Health Information Systems (15%) specializing in hospital coding and billing solutions • Biopharmaceutical Filtration (11%) specializing in compliant purification processing
• Deliver a best-in-class solution portfolio with a low cost-to-serve
How SAP solved a problem for the customer?
3 things that helped drive the strategy
Industry
• Focused Life Science capabilities and roadmap with proven compliance rigor.
•
Medical Device
• Executive point-of-view with key themes of Why SAP for Life Sciences, Why S/4 and Why Private Cloud • SAP facilitated scoping engagement that segmented by must have capabilities to get off of 3M Parent landscape in 24 months + roadmap capabilities for a 5 year target state. • Executive alignment at the CEO and CIDO levels and seamless collaboration with SAP China team.
• Flexible private cloud ERP operational model with package integration to specialized line-of-business solutions for procurement, travel and expense, supply chain planning, manufacturing execution and commerce. • Modern application technologies that improve usability / adoption and productivity (AI/ML, GenAI, IRPA, Workflow), with cloud scalability. • Ability to integrate with 3rd party solutions and deliver required solution extensions without compromising the ability to rapidly adopt future innovations.
Region
•
NA, Midwest MU
MP Name
•
Mark Mueller
INTERNAL – SAP and Customers Only The team involved: ( roles / names) • Christian Klein (CEO); Lloyd Adams (N.A. President); Brian Smith (Midwest MU Regional VP); Tory Larson (Midwest SCP VP); Rob Walsh (VP Strategic Sales); Simon King (VP RISE GTM); Sean Usowski (Director Strategic Sales); Kate Yang (Sales Director SAP China); John Smallwood (Industry AE N.A.); Winston Yin (Industry AE SAP China); Don Rogers (CSD); Stephen Pullen (ISCP); Rakesh Doshi (EA); Jayne Bower (LS Industry Advisor); Prasad Sista (Value Advisory); Solution Advisory (Chuck Mazurek, Lionel Susini, Jim Osborne, Kyle Bethke, Sean McCloskey, Andre Guerrier, Matt Bauman, Jennifer Barron, Tobi Higgott, Matthias Mueller, Kamel El Ghossaini, Subramaniam Balaji, Lee Chapel, Federico Foltynek); Solex Partners Vistex and OpenText; LOB AEs Nick Unterreiner & Sara Stasila (RISE) | Sarah Planken (ISBN) | Ian Steven (RISE CAS) | Mark Hughes (BTP) | Gregg Gabriel (DSC) | Derek Lane (CX); Mark Barrow (MP) for CVS Reference; Sven Schaeffner (MP ) and Laura Prud (IAE) for Fresenius reference.; Katie Nistad (MP) Merck and Organon reference
Links to relevant documents
Reference: Y/N • TBD | Reviewing SAP Flagship program
•
3M Healthcare Spinoff SAP Point-of- View.pdf
50
Made with FlippingBook flipbook maker